Healthcare | August 08, 2021
Metropolis Healthcare PAT at Rs 74.89 crores for Q1FY22
Board approves fundraise of Rs 1500 crore
Board approves fundraise of Rs 1500 crore
India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.
Advances deployment of mRNA technology across vaccines and therapeutics development
In the agreement, Marcor, an Azelis Americas company, will distribute the SPI Pharma product lines in the United States, and Azelis Canada Pharma Division will be responsible for the Canadian marketplace
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
CDSCO to fast-track trials and approval for COVID19 vaccine
Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread
It had an estimated market size of US $ 32 million as of June 2021
Releasing it, Union Minister Jitendra Singh said India needs its database for Indian research and solutions.
Subscribe To Our Newsletter & Stay Updated
